Exact Mass: 457.2498
Exact Mass Matches: 457.2498
Found 144 metabolites which its exact mass value is equals to given mass value 457.2498
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
10,11-Dihydro-12R-hydroxy-leukotriene E4
10,11-dihydro-12R-hydroxy-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 10,11-dihydro-12R-hydroxy-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)
(3S*,3aR*,5R*,5aS*,6S*,10aR*,11R*,12aS*,12bS*)-5-acetoxy-5a-(acetoxymethyl)-2,3,3a,5,5a,6,7,8,9,10,10a,11,12,12b-tetradecahydro-3-methyl-4H-1,6-methanocyclopent[1,8]azuleno[4,3a-g]indole-11-carboxylic acid|macropodumine H
Asp Lys Pro Val
Asp Lys Val Pro
Asp Pro Lys Val
Asp Pro Val Lys
Asp Val Lys Pro
Asp Val Pro Lys
Ile Pro Gln Thr
Ile Pro Thr Gln
Ile Gln Pro Thr
Ile Gln Thr Pro
Ile Thr Pro Gln
Ile Thr Gln Pro
Lys Asp Pro Val
Lys Asp Val Pro
Lys Pro Asp Val
Lys Pro Val Asp
Lys Val Asp Pro
Lys Val Pro Asp
Leu Pro Gln Thr
Leu Pro Thr Gln
Leu Gln Pro Thr
Leu Gln Thr Pro
Leu Thr Pro Gln
Leu Thr Gln Pro
Pro Asp Lys Val
Pro Asp Val Lys
Pro Ile Gln Thr
Pro Ile Thr Gln
Pro Lys Asp Val
Pro Lys Val Asp
Pro Leu Gln Thr
Pro Leu Thr Gln
Pro Gln Ile Thr
Pro Gln Leu Thr
Pro Gln Thr Ile
Pro Gln Thr Leu
Pro Thr Ile Gln
Pro Thr Leu Gln
Pro Thr Gln Ile
Pro Thr Gln Leu
Pro Val Asp Lys
Pro Val Lys Asp
Gln Ile Pro Thr
Gln Ile Thr Pro
Gln Leu Pro Thr
Gln Leu Thr Pro
Gln Pro Ile Thr
Gln Pro Leu Thr
Gln Pro Thr Ile
Gln Pro Thr Leu
Gln Thr Ile Pro
Gln Thr Leu Pro
Gln Thr Pro Ile
Gln Thr Pro Leu
Thr Ile Pro Gln
Thr Ile Gln Pro
Thr Leu Pro Gln
Thr Leu Gln Pro
Thr Pro Ile Gln
Thr Pro Leu Gln
Thr Pro Gln Ile
Thr Pro Gln Leu
Thr Gln Ile Pro
Thr Gln Leu Pro
Thr Gln Pro Ile
Thr Gln Pro Leu
Val Asp Lys Pro
Val Asp Pro Lys
Val Lys Asp Pro
Val Lys Pro Asp
Val Pro Asp Lys
Val Pro Lys Asp
10,11-Dihydro-12R-hydroxy-leukotriene E4
3-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-hydroxybenzenemethanol (2E)-2-butenedioate
7-(4-Benzylpiperazin-1-yl)-3-(3,4-dimethoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine
(5S,6E,8S,10S,13R,14E,16E)-5,10,21-trihydroxy-13-methoxy-6,8,17-trimethyl-2-azabicyclo[17.3.1]tricosa-1(22),6,14,16,19(23),20-hexaene-3,12-dione
5,12-Dihydroxy-6-cysteinyl-7,9,14-eicosatrienoic acid
4-[4-[[1-(2-Methylbutan-2-yl)-5-tetrazolyl]-(6-quinolinyl)methyl]-1-piperazinyl]phenol
1-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-cyclopentylurea
1-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
1-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
2-aminoethyl [2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] hydrogen phosphate
(12R)-hydroxy-10,11-dihydroleukotriene E4
A leukotriene with formula C23H39NO6S that results from the metabilism of leukotriene B4 by human keratinocytes.